This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Inspirmed Corp.. Active years: 2022-2026.
Company Filing History:
Years Active: 2022-2026
Title: Jo-Hsin Tang: Innovator in Pulmonary Disease Treatment
Introduction
Jo-Hsin Tang is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of pulmonary disease treatment through his innovative research and development. His work focuses on creating effective drug formulations that enhance patient care and treatment outcomes.
Latest Patents
Jo-Hsin Tang holds a patent for an "Inhalable liposomal sustained release composition for use in treating pulmonary diseases." This invention provides a liposomal sustained-release composition that includes a polyethylene glycol (PEG)-modified lipid, encapsulating a tyrosine kinase inhibitor. The formulation is designed to be aerosolized or nebulized for inhalation, ensuring consistent pharmacokinetic and pharmacodynamic profiles while achieving desired efficacy and safety. He has 1 patent to his name.
Career Highlights
Throughout his career, Jo-Hsin Tang has been dedicated to advancing medical treatments for pulmonary diseases. His innovative approach to drug formulation has positioned him as a key figure in the pharmaceutical industry. He is currently associated with Inspirmed Corp., where he continues to develop groundbreaking solutions for patient care.
Collaborations
Jo-Hsin Tang has collaborated with talented individuals such as Keelung Hong and Jonathan Fang. These partnerships have fostered a creative environment that encourages innovation and the development of effective treatments.
Conclusion
Jo-Hsin Tang's contributions to the field of pulmonary disease treatment through his innovative patent demonstrate his commitment to improving healthcare. His work continues to inspire advancements in medical technology and patient care.